The ultimate goal of proteomics is to identify, measure, and compare proteins expressed from a given genome under specific biological conditions. Proteomics aims to determine which proteins are present, compare protein expression between normal and diseased conditions, study interactions between proteins, predict cellular behavior, and identify potential drug targets. Because proteins directly carry out cellular functions, proteomics often provides more immediate insight into cell activity than genomics alone. For example, comparing protein expression in healthy liver cells and cancerous liver cells can reveal proteins involved in tumor growth and progression.

Proteomics relies on specialized techniques for protein analysis. Just as the genome is analyzed using the basic technique of DNA sequencing, proteomics requires techniques for protein analysis. The core technique, analogous to DNA sequencing in genomics, is mass spectrometry.

• Mass spectrometry is the most fundamental and widely used analytical technique in proteomics. It enables scientists to identify proteins, quantify their abundance, and detect post-translational modifications that regulate protein function. Continuous technological advances have dramatically improved its sensitivity, allowing reliable analysis of extremely small amounts of protein from complex biological samples. For example, mass spectrometry can be used to compare blood samples from cancer patients and healthy individuals to reveal disease-associated changes in protein expression levels.
• X-ray crystallography is used to determine the three-dimensional (3D) structure of proteins at atomic resolution. In this method, proteins are crystallized, X-rays are diffracted through the crystal and the diffraction pattern is used to build a 3D structure. E.g. the atomic structure of hemoglobin was solved using X-ray crystallography, helping scientists understand how oxygen binds to it.
• Nuclear magnetic resonance (NMR) spectroscopy determines protein structures in aqueous solutions using magnetic properties of atomic nuclei, allowing proteins to be studied in conditions closer to natural environments. Unlike X-ray crystallography, proteins do not need to be crystallized.
• Protein microarrays and large-scale interaction screens, based on methods such as the yeast two-hybrid system, are used to study protein–protein interactions. Because proteomics generates massive datasets, bioinformatics tools and software are essential for data storage, analysis, and interpretation.
• Bioinformatics and Data Analysis: Proteomics generates huge amounts of data, which require powerful computer software and databases for analysis, storage, and interpretation. E.g. software tools are used to match mass spectrometry data to known protein sequences stored in databases such as UniProt.

Challenges in Proteome Analysis

Despite major technological advances, proteomics still faces several important analytical challenges. Many proteins exist in extremely low abundance, making them difficult to detect even with highly sensitive instruments. Proteins are also inherently less stable than DNA and can degrade during sample collection, storage, or processing, which complicates accurate measurement. In addition, protein expression varies widely across tissues, developmental stages, and disease states, creating complex biological backgrounds that are difficult to interpret. Although mass spectrometry has greatly improved detection limits, subtle but biologically meaningful changes in protein levels under disease conditions can still be challenging to distinguish from technical or biological variation.